Skip to main content

Table 1 Baseline demographic characteristics

From: The Relationship between Pulse Wave Velocity and Coronary Artery Stenosis and Percutaneous Coronary Intervention: a retrospective observational study

Variables

Group 1

Group 2

p-value

(1 vs 2)

Group 3

Group 4

p-value

(3 vs 4)

p-value

(1/2 vs 3/4)

Age (year)

58.9 ± 10.04

59 ± 10.89

0.896

63.88 ± 8.32

61.41 ± 10.04

0.020

<0.001

Male (%)

182 (55.83%)

259 (56.67%)

0.814

84 (70%)

148 (77.89%)

0.119

<0.001

Symptoms

 Asymptomatic

70 (20.5%)

66 (14.4%)

0.001

75 (62.5%)

96 (50.5%)

0.078

<0.001

 Atypical chest pain

127 (39.0%)

149 (32.6%)

15 (12.5%)

24 (12.6%)

 Typical chest pain

129 (39.6%)

242 (53.0%)

30 (25.0%)

70 (36.8%)

 BMI (kg/m2)

24.9 ± 3.09

24.71 ± 2.97

0.391

24.68 ± 2.8

24.99 ± 3.04

0.356

0.683

 Smoking (%)

97 (29.75%)

138 (30.2%)

0.894

38 (31.67%)

51 (26.84%)

0.360

0.671

 Hypertension (%)

191 (58.4%)

266 (58.3%)

1.000

108 (90.0%)

180 (94.7%)

0.172

<0.001

 Diabetes mellitus (%)

61 (18.71%)

82 (17.94%)

0.784

46 (38.33%)

50 (26.32%)

0.026

<0.001

 Dyslipidemia (%)

95 (29.14%)

149 (32.6%)

0.302

102 (85%)

164 (86.32%)

0.746

<0.001

 CKD (%)

69 (21.23%)

110 (24.07%)

0.352

42 (35%)

53 (27.89%)

0.186

0.008

 Uric acid (mg/dL)

5.14 ± 1.48

5.25 ± 1.44

0.337

5.3 ± 1.63

5.42 ± 1.34

0.493

0.085

 Hba1c (% of THb)

6.19 ± 1.04

6.29 ± 1.41

0.539

6.48 ± 1.08

6.02 ± 0.82

0.005

0.644

 TC (mg/dL)

147.8 ± 89.48

157.3 ± 103.2

0.168

123.7 ± 63.19

133.7 ± 80.2

0.226

<0.001

 LDL-C (mg/dL)

96.5 ± 26.88

96.13 ± 27.24

0.853

72.64 ± 20.31

73.07 ± 21.8

0.860

<0.001

 HDL-C (mg/dL)

51.31 ± 13.57

49.95 ± 12.83

0.157

48.1 ± 11.29

46.89 ± 11.36

0.361

<0.001

 Triglyceride (mg/dL)

137.5 ± 89.21

152.3 ± 105.9

0.036

119.6 ± 67.36

129.9 ± 82.59

0.231

<0.001

 Creatinine (mg/dL)

0.96 ± 0.46

0.95 ± 0.23

0.672

1.06 ± 0.65

1.02 ± 0.2

0.479

0.003

 hsCRP (mg/L)

2.74 ± 8.99

2.15 ± 5.68

0.324

2.01 ± 4.32

1.82 ± 4

0.701

0.162

 #, risk factorsa

2.23 ± 1.39

2.29 ± 1.35

0.579

3.67 ± 1.25

3.48 ± 0.97

0.152

<0.001

Index Medications

 ACE inhibitors (%)

12 (3.68%)

15 (3.28%)

0.763

35 (29.17%)

55 (28.95%)

0.967

<0.001

 ARBs (%)

87 (26.69%)

101 (22.1%)

0.139

52 (43.33%)

68 (35.79%)

0.184

<0.001

 Beta-blockers (%)

35 (10.74%)

62 (13.57%)

0.236

47 (39.17%)

88 (46.32%)

0.216

<0.001

 CCB (%)

84 (25.77%)

135 (29.54%)

0.246

47 (39.17%)

83 (43.68%)

0.432

<0.001

 Diuretics (%)

27 (8.28%)

28 (6.13%)

0.245

12 (10%)

15 (7.89%)

0.522

0.340

 Insulin (%)

2 (0.61%)

2 (0.44%)

1.000

4 (3.33%)

5 (2.63%)

0.739

0.003

 Statins (%)

77 (23.62%)

116 (25.38%)

0.573

102 (85%)

163 (85.79%)

0.848

<0.001

  1. BMI body mass index, CKD chronic kidney disease, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, ACE angiotensin-converting enzyme, ARB angiotensin receptor blocker, CCB calcium channel blocker
  2. aRisk factors included old age (≥65 years), male gender, smoking, hypertension, diabetes mellitus, and dyslipidemia. Data are presented as means ± SDs for continuous variables and numbers (%) for categorical variables